Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid

David Hsiehchen1, Andrew Elliott2, Joanne Xiu2

  • 1Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Cancer Cell
|November 22, 2024
PubMed